N
Google TrendGME (1000+) — GameStop Stock Hits a New 52-Week High: What's Going On?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:gme1000+pope francis200+nicolò tresoldi500+michael olise1000+bank of america fine1000+club brugge500+rb leipzig200+saudi news1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Real-world outcomes of Ad" (30 stories)

Top Headline Story

Three-year real-world outcomes of faricimab in pretreated eyes with treatment-resistant neovascular age-related macular degeneration
Lead StoryNatureworld
Oct 2

Three-year real-world outcomes of faricimab in pretreated eyes with treatment-resistant neovascular age-related macular degeneration

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0NjBoNDg1X0Jwa181TVo0dlVvNjk3eFpkYWZ5Z2ZCd0ZHZnFhZUtsM0JJcTlXWS1HbzZhcU0zYWd3ZHF3ODF6TFhiS21KVjdta3pJdnlIRjc3NTdHQWlN?oc=5" target="_blank">Three-year real-world outcomes of faricimab in pretreated eyes with treatment-resistant neovascular age-related macular degeneration</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
1000+21m ago

gme

GameStop Stock Hits a New 52-Week High: What's Going On?

Filter stories
200+21m ago

pope francis

The Myth of St. Francis

Filter stories
500+31m ago

nicolò tresoldi

Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League

Filter stories
1000+31m ago

michael olise

The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu

Filter stories

Search Results for "Real-world outcomes of Ad"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Dupilumab Data at EADV 2026 Highlight Outcomes Across AD, CSU, and Prurigo Nodularis
Dermatology Timesgeneral

Dupilumab Data at EADV 2026 Highlight Outcomes Across AD, CSU, and Prurigo Nodularis

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNVFNRNE1RdVJUS0FUeXZZTHBiUHlZMjBwdzJvR1ZXMXFQU2JBd0lTWEN6eHAzMFlBT19ESXo3SFp1NXctdzk4SVlLUnZZZTI0OVJ4emRpYUJZVUt1dTlhMGFISTljOTVwZ09aSWhxU3F6S3NuYTVSQ0c2RUJDU3BzRDhDMWtoVmRHUURIMVJHaVpiQllpYU9fVXZlWlEwS1RSbzlCWFZqS3JUZ013R2Z2aXdFeGdMc3dEcTY3Sg?oc=5" target="_blank">Dupilumab Data at EADV 2026 Highlight Outcomes Across AD, CSU, and Prurigo Nodularis</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
Real-World Outcomes for Mosunetuzumab, Epcoritamab Similar to Trial Findings in rrFL
Cancer Therapy Advisorworld

Real-World Outcomes for Mosunetuzumab, Epcoritamab Similar to Trial Findings in rrFL

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPVDhNMHhUQmJrS1BTeTFlaDktRVphbm5pc0xvNTQ3b3NXaFRMU1k3Y24tR0MzdXlyc0xoOVdXSzg5NzBsMENMT1hPdm1JNTdETDNvU3h0andOWlZpcFpRVS1aTkZXQ3Q2RFBHdXBRRHB5WVNwTFlfV19Fc3ZkSExhVENIUzU1QVNMY1ZZRkF3X2hNeTZnMDliVUJIbEtXeEx2bWxiSVdLUU9HUjh6MXBkMg?oc=5" target="_blank">Real-World Outcomes for Mosunetuzumab, Epcoritamab Similar to Trial Findings in rrFL</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Read Full StoryMore like this
UVA study evaluates safety and real-world outcomes of histotripsy
News-Medicalworld

UVA study evaluates safety and real-world outcomes of histotripsy

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPVDUtOERORlVLYnU1VGQweWR0VTF1azhXamVQakVfM1pQSjdRRmwzUGpJVzJxcXZJLUNJZlprYWFrcVc5M2pzWWNuaUxHTDAySGphenIyaGV2UzhQV1hxVXlEUk8yZXIwMlRqLWhfdWVwejdRMGFOYS1wR1hvdEhMT1M0OXVyZVQzNkVfVnlkc2hlTDBkam54eEdMalJ6UXNIOG9LZ0cwYzVqSl9CaE5tQzN1VQ?oc=5" target="_blank">UVA study evaluates safety and real-world outcomes of histotripsy</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
Infillion to Acquire Foursquare, Closing the Loop Between Advertising and Real-World Results
Newswireworld

Infillion to Acquire Foursquare, Closing the Loop Between Advertising and Real-World Results

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPczByTXFXU0lfU1Z1STN0SzlOaUxyMlZLdEdpYTdIcERPYUIwNTl0N1B2X1VJTDhYQWoyNVNOTklfWDNSX3VTT24xQlVtSzMyZnp1Y0RKT0dIVVgzaE5YX2xtUUstblpyRmdCY0llUlFQV2R2UFFIVWEwWGRVOUhCUVpVYktmUGx4OUdkblFSVDVMWVdGdDFvdm1aZWxWLUxRemtzTVBma3VLOTg?oc=5" target="_blank">Infillion to Acquire Foursquare, Closing the Loop Between Advertising and Real-World Results</a>  <font color="#6f6f6f">Newswire</font>

Read Full StoryMore like this
70 Real-World Outcomes and Toxicity of Trastuzumab Deruxtecan in Older Adults With Breast Cancer: A Mayo Clinic Multi-Site Analysis
CancerNetworkworld

70 Real-World Outcomes and Toxicity of Trastuzumab Deruxtecan in Older Adults With Breast Cancer: A Mayo Clinic Multi-Site Analysis

<a href="https://news.google.com/rss/articles/CBMi-AFBVV95cUxOcXNpdDBSNW1MRkI3ZXppdXVrelR3QXd6aVJfODYxckxmR244MlFtVW02X1I5QUtURWdMVVZlSzJJX19VaS1sX2RoR1dWcGhvLUMxWWR4eFhPS3NaWlVsN0tDLVFaQnFIWHY1Zk55SGV3UXRmMm5vdms5Y0o1bDc2bGxpclFPXzlWLTlfTGppWnA3MDhLeWREdVAyRGlLb1JrVktReEdiNkplQ3VSSzhkczZRQUN3LU9sZl85bnJaNFRhQmxqb0psN0RCV0J1NUc3OUV1MEg1bGJuV3pZajFPTF9WZjl3b1BpdTQzd2ZYMW95UnU4U3RGNA?oc=5" target="_blank">70 Real-World Outcomes and Toxicity of Trastuzumab Deruxtecan in Older Adults With Breast Cancer: A Mayo Clinic Multi-Site Analysis</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas
BioSpaceworld

LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas

<a href="https://news.google.com/rss/articles/CBMiywJBVV95cUxOY1k5bHFjWE5tT3ZIT3JuYkFVQjNMSzJHb3p4dGdZVUZzUktJVE5IR3RTZGduZzNHeEFuMThxRmlTYXdlR295VUg5OHFjR0N3NnBHcmhaTXVzMS1jcE9oVUR2dHpIOTZRMF8zWjFFWF9lclVVYUF2X3hpMDVMODZnaXBHcUNDOFhoUlVhNWdRSVVoaEtBQ0RYMGpSV2lmcHVCeWU5dTFqc3V4bndnTFdoWnZDZl9WYVk2Vm14UmFvTlozdDgwM2tDdzZLNi1BREtRYi01SGttclRXM3ZQSG1oUHJKQnRoLV95S1NBYnY0bFdwX0g1VkRDLTUzX1ZsVy0wYTNWTlZhSnRyMmJuZ0NLZ3pmbzgzd2ZPeGFzTWxmbHFYQ0MzU3VTR1pFaUs2cXhxaXk1dmZFNVRVZENFNF94a05aa09WUFRWWC1r?oc=5" target="_blank">LEO Pharma presents new tralokinumab data at EADV 2026 highlighting real-world outcomes and quality of life in adults and adolescents with atopic dermatitis (AD) involving high-burden areas</a>  <font color="#6f6f6f">BioSpace</font>

Read Full StoryMore like this
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026
Biogenworld

Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNWFhDeTctS1BfMzZNY1FsTDhINFo4QUFheExoUkd0UDVsN0tTRGJXWjZ5dHBoY05HcVgtUjJTRTdfYW5OcEVyUEFIODRXb3lEWkNiWE5JTkV2Zm14ME9YNzNXekh3UW5VeTM5YVdEREhLMGFMdkZnUlNnUzRtbDN6R3pCNXBwdkM0UFFjNXNCcHVKVnlZUXdjY2h3YmprY193NmNNMTVRQU95VmtOY3NJcGlINDJfeDFhQmRRMGVXeHo?oc=5" target="_blank">Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026</a>  <font color="#6f6f6f">Biogen</font>

Read Full StoryMore like this
Navigating Efficacy Benchmarks and Real-World Outcomes in Metastatic Colorectal Cancer
Oncology Nursing Newsworld

Navigating Efficacy Benchmarks and Real-World Outcomes in Metastatic Colorectal Cancer

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPZ3ZsMGx0SHRNVlRaakFiS21JaXNUZGdub3BuUjNWSldMZHZFV2UzSUlGQUZrSjBkaFExV1RmZFFMS1FDOTBUd1AzWVltSmZqeGtmS1pXRS1xcDNiQ2RSdjV6UzRvU2pPM1dsY0ZoZzluQVJCUTFRdkx3VVhNNnJNdndIdmdxTHM0SEhRZFJ5U0gwUlRwMFd0bUpxR2RQX0xHT0Q0Vi14aTU1LVJ5a3laMHp6ZmRfU3hueG5UQjNnUQ?oc=5" target="_blank">Navigating Efficacy Benchmarks and Real-World Outcomes in Metastatic Colorectal Cancer</a>  <font color="#6f6f6f">Oncology Nursing News</font>

Read Full StoryMore like this
More than 2,300 psilocybin users report real-world outcomes in Oregon and Colorado
Medical Xpressworld

More than 2,300 psilocybin users report real-world outcomes in Oregon and Colorado

<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPYmhZUmtLb0lpUnhWWEU1anRTSVcxUnRRZzZhTlYyM0ZzaFFJbFR2clJTSVQ1aGRUM3NDY3FTTE1GejdJSHFWV24wRDNjYUJpV0JaWDZsNE1fcVRWMjFER3ViOWxrSFNpOXhHUHRZMHc4anV0WTI1RUVYaWxMXy0tblVlejNaSTQ?oc=5" target="_blank">More than 2,300 psilocybin users report real-world outcomes in Oregon and Colorado</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
Beyond the Trial Population: Real-World Outcomes With T-DXd in HER2-Low Metastatic Breast Cancer
DocWireNewsworld

Beyond the Trial Population: Real-World Outcomes With T-DXd in HER2-Low Metastatic Breast Cancer

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPSzZtU0p1OEY3MUZoSWExX01DVTlXSy1mRDlQQ3U3VFptem56eW92SzVLaS10MV9pdFFFRlUtQzAyV3NzbDNSay1TZmVjQmR5VnpXU2l6NElOSWNmSDJ2dTFxREQtUXQ3Y1BkQXBXR3M1ajNTMTB2SzR0aFp0YjFkMTNaM21oZHZ3QlRKVlZXczg2cmd2cnhmNXAxVl9ZSGJITzlpMWo4OG81cDZDQmYyQXptc0hGRl9oWEJ6a1JKcG9kcjdGak5n?oc=5" target="_blank">Beyond the Trial Population: Real-World Outcomes With T-DXd in HER2-Low Metastatic Breast Cancer</a>  <font color="#6f6f6f">DocWireNews</font>

Read Full StoryMore like this
CLL14 Frontline Combo Results Bolstered by Real-World Outcomes
AJMCworld

CLL14 Frontline Combo Results Bolstered by Real-World Outcomes

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQdF9lZnRTcXNqVW1ONVBkNXFqRmI4QmdWWVlScGZkV0RDako3clYyT0l5WEJ0N2duNndWU3J3RVZUMEpaUmpkcHMtRnNJOXpfR3dyVG1BTjZZaWlfZXRaZ3ZvWGZuTEtGZmRrY2xhcHZ3WjhFaWtRMXMybHFveHpidzFZbzg2UTQ0YnJ0X281NGtBUQ?oc=5" target="_blank">CLL14 Frontline Combo Results Bolstered by Real-World Outcomes</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
Daily Research News Online no. 40416 - Infillion Buys Foursquare, Linking Ads to Outcomes
MrWebtech

Daily Research News Online no. 40416 - Infillion Buys Foursquare, Linking Ads to Outcomes

<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFBESlNHeEZKQ3Z4Z0dyUEhETlZESHdmNVlXQ1JNelFYSjBwaXlBbWJYNklPMDAtS0pHZlEtQVVoa2EwYkZMWDdaWnBYN1Q4b2VCM2c?oc=5" target="_blank">Daily Research News Online no. 40416 - Infillion Buys Foursquare, Linking Ads to Outcomes</a>  <font color="#6f6f6f">MrWeb</font>

Read Full StoryMore like this
GLP-1 RAs May Reduce Mortality In Some Patients With Colorectal Cancer and Comorbid Obesity: Real-World Outcomes
The ASCO Postworld

GLP-1 RAs May Reduce Mortality In Some Patients With Colorectal Cancer and Comorbid Obesity: Real-World Outcomes

<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxPdjhuUEJYbEJRT3NnM3NVUExsUkhYTjFWY1Z3czZqSHJhdDZqdENiVllVSndlR1ZBRmRhVjVvWWlvYXhCTm9KeEtVcl9OU1BXRFVZUkpNNmRuVWM2Q04zYmIxZHdDM3ZYOW1SS3JKZmI3d1p5bmcyVGQ5Q3hIOW5KQ25pSzh6ZUgyblZSTEFSLTQtSUxGcW1lRUF0U1J6MHVlV3E2MU5Lb2tUOGtyS0tScTJHbkljVDR2Q18ydF9PRjJSZlN3enlvYnQ4UlhSQnlHVVBnQmRmbFJ6d0s0MVJ6WDAwY01RYzZDaHc?oc=5" target="_blank">GLP-1 RAs May Reduce Mortality In Some Patients With Colorectal Cancer and Comorbid Obesity: Real-World Outcomes</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Real-World Outcomes of Colorectal Signet Ring Cell Carcinoma: Clinicopathological Characteristics, Treatment Patterns, and Survival
The Cureus Journal of Medical Scienceworld

Real-World Outcomes of Colorectal Signet Ring Cell Carcinoma: Clinicopathological Characteristics, Treatment Patterns, and Survival

<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxPc2RoWkVoR1NxbllSb0xOX1hwRjVjTGcwYjIwRDhWNkxCbUlxU0dRUkZDZUhRT204MVlSVDhEUmVqdFJTWEJ1VVhCbndLMkdIbWYwcVM5WVNoTExiS2FoRjFNU3pvaWhmdG85Smt4LTg4V3RqVlRPb1dtZ2xXaXZkbnZqUFdvNnplRHY5YTVjX2pyeUFuNlVLeXFPaTc4MGVBdXc3WXlBZm83QkRQcGpHbS1iZ0ZPOFdWZG5DOVBncjhxd2JaTFNWN0lqTDNuWTBKZ2tFaS1HTzNNelZOcmdTRHZkbGF2YUExYjBtMXFkenJwb1kwOFlrMV8wTQ?oc=5" target="_blank">Real-World Outcomes of Colorectal Signet Ring Cell Carcinoma: Clinicopathological Characteristics, Treatment Patterns, and Survival</a>  <font color="#6f6f6f">The Cureus Journal of Medical Science</font>

Read Full StoryMore like this
Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities
Natureworld

Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE80TGEydUt0enlLb3ByU0RLVzV2MHZOWm9pekhqbGdVYWc0WUtSZ3hlUHB5dExya1lmY0dJMEl2b0x4QUZCWEZqY3NwbThoY1V4MTdfX05wYklYQ3VON3FN?oc=5" target="_blank">Real-world outcomes of immunotherapy in advanced NSCLC patients with comorbidities</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal
Natureworld

Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0yNktMcld5Y2ljeFg0WU1EVXVOdk9FUERsVDlpVTBfQ3JQY0tESEFYZkhIYjVyMGtKdlNKRk5PSVU3b2ZYc3kxN2xSZldzRUZOUWhYNVlEckE4dlEwOFQw?oc=5" target="_blank">Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study
Natureworld

Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9vSk8ydHMyU1hmNTlLaWxEUG93U3JCNEkxSGE4V1h2Z1lsU0lSdkt2bTlta1hGYVN4R3o5aTFFSGZMY1ZoYlRWUU1lTENWcDgteGk4VnNzOEIxRGtqbWd3?oc=5" target="_blank">Aflibercept biosimilar use and real-world outcomes in various retinal diseases: the AURA Korea study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service
Natureworld

Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE01ZTVwbk5COUZoR0RETTdNNGtjRzFZOG4xU1B6ZURHWnNXQlEyX3JWSmx4ajlfbGVWTE14UC1tX3ZhZUxCbHNmYlIwNjdTOGptU0twbFNiUjNodXVHcFVz?oc=5" target="_blank">Real-world outcomes following adjuvant chemotherapy for resected pancreatic cancer in a centralised oncology service</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-world outcomes of hybrid obesity care using digital coaching and GLP-1 therapy in a multi-ethnic Asian setting
Natureworld

Real-world outcomes of hybrid obesity care using digital coaching and GLP-1 therapy in a multi-ethnic Asian setting

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE54SmY1SUJFOHc2MmRkazE1cmlhanl3STFUNV9jSnF6V3lmYzJmU1NDUEpJUzhVTUw1bFFGU1JaN1BOMmhIQVI0QjgzSFo4OTRYSkhVdUppbEJlNlpsemlV?oc=5" target="_blank">Real-world outcomes of hybrid obesity care using digital coaching and GLP-1 therapy in a multi-ethnic Asian setting</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-World Outcomes With Atezolizumab Plus Bevacizumab vs Durvalumab-Based Therapy
CancerNetworkworld

Real-World Outcomes With Atezolizumab Plus Bevacizumab vs Durvalumab-Based Therapy

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQUm9hUHpZcjV6YXdrMldxMTFFV3JGc21MYlpiZ0ZzdHpWTXBMMEp0NDk4MnExOTFWUXRwQVVyX19tZURZd25hQkhzN2k5dnFYOTZPMFFZcUZnUGpKalRDcXcxSFA0N1U1YWxpSjBYaVBBdHFIMjM4VEd6YUFLWk8wZHBKOGxmZExWLXAtODJ5Um1tdkhMUjNRRWt3aml2ZUkwZ3MxamFib1dkcmtIVVhfRzRVTDI4bkla?oc=5" target="_blank">Real-World Outcomes With Atezolizumab Plus Bevacizumab vs Durvalumab-Based Therapy</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma
Natureworld

Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBneGthaS0tT2VzV2xXSGV0cEFyaVRDbG5pY0ZwbGVJVzdpa3FwSXFMOEg1V1RBZGxCdWtfaVJnSVZwZE5MVnZnQXRTaHRHc19EYWN4R1dnY1MtM2cxbHFr?oc=5" target="_blank">Real world outcomes of intravitreal and systemic therapy in primary and secondary vitreoretinal lymphoma</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Real-world outcomes of ketogenic diet therapy in children with drug-resistant epilepsy in a prospective cohort study
Natureworld

Real-world outcomes of ketogenic diet therapy in children with drug-resistant epilepsy in a prospective cohort study

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5TR3owMG5McmxyMmplV0F3Z3VMREZKV255Z21GblBRZmpLZ1o3Z0FleG5LTkNEeDRsNl9QV3dQWXo1WDRYTVdWcERZc212VnpvQ19nMlQ0cExtcTRScEl3?oc=5" target="_blank">Real-world outcomes of ketogenic diet therapy in children with drug-resistant epilepsy in a prospective cohort study</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Abemaciclib plus fulvestrant in treating hormone-receptor positive, HER2-negative advanced breast cancer—comparing real-world outcomes in England to the MONARCH-2 trial
Natureworld

Abemaciclib plus fulvestrant in treating hormone-receptor positive, HER2-negative advanced breast cancer—comparing real-world outcomes in England to the MONARCH-2 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAyZy1hMGNUbGtOeEtOUjE5cXZ5bzY1ZFFLYTRWc2U1UnNWSU51WWJNZURDbFptWENRX1d2VzVTY3IwQS1jRDU1aENRMW5UTmJqb2VMWmNldXBwRUgxYXlF?oc=5" target="_blank">Abemaciclib plus fulvestrant in treating hormone-receptor positive, HER2-negative advanced breast cancer—comparing real-world outcomes in England to the MONARCH-2 trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Andrew Portuguese, MD, on Multiple Myeloma: Real-World Outcomes With Elranatamab
The ASCO Postworld

Andrew Portuguese, MD, on Multiple Myeloma: Real-World Outcomes With Elranatamab

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOb011cURwb3AzZ0g1QUExUmNYcDhkNXliWEZZZWptMDk3QjRteEU1QUszbDNWLTNyQkN5VWEzaW1KdXVQVGpIT2xpb21ZM0tIY1c2QWJ0cmF6eWZXZVJPV2RFV2dZN3ZpOExXOEIwZjk0bnNnNGEtTnZTeXhxQl9Ta3NhVWZMakVqX0l4Sl9NVndpNW9yVVE?oc=5" target="_blank">Andrew Portuguese, MD, on Multiple Myeloma: Real-World Outcomes With Elranatamab</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Early real-world outcomes of aflibercept 8 mg in previously treated neovascular age-related macular degeneration
Natureworld

Early real-world outcomes of aflibercept 8 mg in previously treated neovascular age-related macular degeneration

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAxVzJMdGlZZmFmVk1XWlJBN2steUtmb19aNzBiUWVSckxpLVJscGtHQ0VGVGZkdGZkLXN5YjdWYjY0YkRFelR2VlJsLUxOQkc1SFZlR2tHNm5QVk1KdnAw?oc=5" target="_blank">Early real-world outcomes of aflibercept 8 mg in previously treated neovascular age-related macular degeneration</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
InMarket Launches Maestrø: The First Agentic Media Optimization Platform to Guarantee Real-World Outcomes Across Platforms
Business Wiremarkets

InMarket Launches Maestrø: The First Agentic Media Optimization Platform to Guarantee Real-World Outcomes Across Platforms

<a href="https://news.google.com/rss/articles/CBMiiAJBVV95cUxOeDlhR0ZLWjhjVkRuNWxGalRqamw2TEktTzFrenlGLUxQZkFmSVN6Q1NQSGQyaXVNdklWdFAyeWZQTE5oUzNFTjhBZFQyRC1xQUU4Q2ZDNkU0SXZLdHQ3NDlxWlNxS3hRT29kOFV0NWtDMmVvNlI5bmh0ZS1zRGxlX25kUmVnYm9QVzB2dUZ3bktENlg0NDJLSUtWRlRHUEIwWjhLMmRYQm1aMjEzNTNDWGtpdFJhSGVnYTlNVW9HbnZRYmhJX2dHc01iQXhPbFV6bDctLWVOREZDRy1Wb1FHY1BWYlBMZlpEb1dsM3BQLTNyX2RiWHNuLTNlMVNBT2tid2t4TTFpWEk?oc=5" target="_blank">InMarket Launches Maestrø: The First Agentic Media Optimization Platform to Guarantee Real-World Outcomes Across Platforms</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
LAMPOON in TMVR: Glimpse Into Real-world Outcomes
TCTMD.comworld

LAMPOON in TMVR: Glimpse Into Real-world Outcomes

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBXVU5SY2xXSF95ZmhpUk9jd1VGVnJPXzZxR013SEdweTg2cTlzT2g5SkgtTmlWSlkxbDVJWUZsQmwzaW1kYnUyRkVjNTVrbmpVVVgyWEpsU3dTM3JmQlN2VWMyano1dS1sMWhLYWRiUG9EamVNRmc?oc=5" target="_blank">LAMPOON in TMVR: Glimpse Into Real-world Outcomes</a>  <font color="#6f6f6f">TCTMD.com</font>

Read Full StoryMore like this
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
Ophthalmology Timesworld

DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxQeXNqWUxjX2RjMmI1QzFfVnBlU0tHYkVBUXhfZ0YxQlZQOFp5MEVhUjNMUEdqZHU2YklWR2tJSU9zM3pOejNBVndpRkQ5SURSMzl3TUVDeDB5V1hwMUlid2gwbTlKYlBYSEtGekhObkZvc05tbWd5bVc0aEtiazJwUFVYX0RKanhnUjc5N2FRNGFMbjhPLWtrYmlQUEVib0Ffc3JpWTdrRjliZnBiNnpfeVA3dw?oc=5" target="_blank">DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes</a>  <font color="#6f6f6f">Ophthalmology Times</font>

Read Full StoryMore like this
Real-World Outcomes of Adjuvant Pembrolizumab for Renal Cell Carcinoma: The Potential Role of PD-L1 as a Prognostic Biomarker
springermedicine.comworld

Real-World Outcomes of Adjuvant Pembrolizumab for Renal Cell Carcinoma: The Potential Role of PD-L1 as a Prognostic Biomarker

<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQV056WnBOZHBSaHRhejYtSndVRnVDTFpFQ2R6ZHFUWENEU0gwcnBJV01VMnpiR1pNXzNPSm5nZXBaMXhoYnB4RGtDZW81TWNzcHRLdkpFZmZwUGo3azNhSDRQdkpxaWx1ZWZkdEd6VGI0UVdlNWNxSXdPNG9ZZWpueW5jdkhrNFUyR0dGMGc1VUxDNG9kbmw2TjZIQjM5UjZaX1VjUHo5VXFBNFJpVTFjeHh5enA2Mk8wbmJudDVlWExvTzZRbS1nbzR6Q3NULVNxUnd3aFpsUmM2dTRJWThmZ0pR?oc=5" target="_blank">Real-World Outcomes of Adjuvant Pembrolizumab for Renal Cell Carcinoma: The Potential Role of PD-L1 as a Prognostic Biomarker</a>  <font color="#6f6f6f">springermedicine.com</font>

Read Full StoryMore like this
"Real-world outcomes of Ad" — Live Google News Trends & Headlines